Ebook: Nuclear Signaling Pathways and Targeting Transcription in Cancer

At the moment, there is no dedicated book to summarize the roles, the significance, and potential therapeutic targeting of transcriptional factors from the perspective of signaling cascade, and thus, directly impacting the functionality of transcriptional factors in cancer. In addition, this book will offer a comprehensive basic and clinical science behind the functions of representative core transcriptional factors. These chapters will serve as a treasure for all those who have an interest in the basis, progression, and targeting of human cancer. Each chapter will be intended to provide comprehensive, up-to-date information by the leaders about the physiologic and pathologic roles of TFs in specific representative organ systems of prime importance. The book will consist of chapters that will give biomedical students, under and graduate students, basic sciences and clinical cancer fellows, residents and researchers, and oncology educators will get a thorough summary of the overall subject. The readers will be able to understand the important current information and views on specific TFs and its role in cancer in areas outside their own expertise or experience. A special emphasis will be also placed on the "classic" papers as well as perspectives on future directions for the field.

---

This book presents the most up-to-date information in the area of targeted therapeutics with a particular focus on pathway-centered approaches and transcription by leading authorities in molecular cancer research. The goal is to cover several critical principles of cancer therapeutics, ranging from regulation of cancer associated genes by coregulators, cancer cell signaling, modifiers of epigenome functionality and specific protein domains, and emerging significance of splicing. The book is directed for basic and translational scientists, clinicians, clinical investigators, fellows, residents, graduate students, and educators in the areas of molecular therapeutics and cancer medicine, and medical sciences at-large. Readers will be able to grasp the overall importance of the pathway, associated pathobiology and clinical manifestation, and possible points of intervention with a goal to solidify new cancer therapeutic targets.

---

This book presents the most up-to-date information in the area of targeted therapeutics with a particular focus on pathway-centered approaches and transcription by leading authorities in molecular cancer research. The goal is to cover several critical principles of cancer therapeutics, ranging from regulation of cancer associated genes by coregulators, cancer cell signaling, modifiers of epigenome functionality and specific protein domains, and emerging significance of splicing. The book is directed for basic and translational scientists, clinicians, clinical investigators, fellows, residents, graduate students, and educators in the areas of molecular therapeutics and cancer medicine, and medical sciences at-large. Readers will be able to grasp the overall importance of the pathway, associated pathobiology and clinical manifestation, and possible points of intervention with a goal to solidify new cancer therapeutic targets.

Content:
Front Matter....Pages i-xii
Front Matter....Pages 1-1
Steroid Receptor Coactivators (SRCs) as Integrators of Multiple Signaling Pathways in Cancer Progression....Pages 3-32
Role of Alteration/Deficiency in Activation (ADA) Complex in Cell Cycle, Genomic Instability and Cancer....Pages 33-55
RUNX2 Transcriptional Regulation in Development and Disease....Pages 57-86
Epigenetic Mechanisms of Cancer Metastasis....Pages 87-104
Front Matter....Pages 105-105
Regulatory Effects of Arsenic on Cellular Signaling Pathways: Biological Effects and Therapeutic Implications....Pages 107-119
Nuclear Factors Linking Cancer and Inflammation....Pages 121-154
Regulation of the Jak/STATs Pathways by Histone Deacetylases....Pages 155-187
Receptor Tyrosine Kinases in the Nucleus: Nuclear Functions and Therapeutic Implications in Cancers....Pages 189-229
Nucleolar Signaling Determines Cell Fate: The RP-Mdm2-p53 Axis Fine-Tunes Cellular Homeostasis....Pages 231-257
Transcriptional Regulation of Lipogenesis as a Therapeutic Target for Cancer Treatment....Pages 259-275
Front Matter....Pages 277-277
Selective Inhibition of Acetyl-Lysine Effector Domains of the Bromodomain Family in Oncology....Pages 279-298
Domain Specific Targeting of Cancer....Pages 299-310
Front Matter....Pages 311-311
The Potential of Targeting Splicing for Cancer Therapy....Pages 313-336
Exploiting Cell Cycle Pathways in Cancer Therapy: New (and Old) Targets and Potential Strategies....Pages 337-372
Histone Demethylases in Prostate Cancer....Pages 373-397
Therapeutic Significance of Chromatin Remodeling Complexes in Cancer....Pages 399-422
Back Matter....Pages 423-439